Julia J. Witjes

1.7k total citations · 1 hit paper
10 papers, 977 citations indexed

About

Julia J. Witjes is a scholar working on Molecular Biology, Physiology and Epidemiology. According to data from OpenAlex, Julia J. Witjes has authored 10 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Epidemiology. Recurrent topics in Julia J. Witjes's work include Gut microbiota and health (4 papers), Diet and metabolism studies (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Julia J. Witjes is often cited by papers focused on Gut microbiota and health (4 papers), Diet and metabolism studies (4 papers) and Liver Disease Diagnosis and Treatment (3 papers). Julia J. Witjes collaborates with scholars based in Netherlands, Denmark and United States. Julia J. Witjes's co-authors include Max Nieuwdorp, Joanne Verheij, Adriaan G. Holleboom, Karine Clément, Judith Aron‐Wisnewsky, Chloé Vigliotti, Phuong Thi Le, Anne Linde Mak, Torsten P. M. Scheithauer and Aart J. Nederveen and has published in prestigious journals such as PLoS ONE, Frontiers in Microbiology and European Journal of Pharmacology.

In The Last Decade

Julia J. Witjes

10 papers receiving 971 citations

Hit Papers

Gut microbiota and human NAFLD: disentangling microbial s... 2020 2026 2022 2024 2020 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia J. Witjes Netherlands 9 626 550 370 218 93 10 977
M.L. Gabrieli Italy 4 980 1.6× 507 0.9× 424 1.1× 333 1.5× 251 2.7× 7 1.3k
Maya Margalit Israel 17 508 0.8× 294 0.5× 148 0.4× 212 1.0× 123 1.3× 46 1.1k
Nadine Gehrke Germany 15 351 0.6× 391 0.7× 114 0.3× 111 0.5× 136 1.5× 22 1.0k
Aloysious Aravinthan United Kingdom 16 423 0.7× 248 0.5× 270 0.7× 62 0.3× 270 2.9× 40 1.0k
G.L. Rapaccini Italy 11 1.1k 1.8× 551 1.0× 430 1.2× 371 1.7× 339 3.6× 23 1.5k
Bo‐Ram Bang United States 17 193 0.3× 332 0.6× 329 0.9× 46 0.2× 119 1.3× 30 1.0k
Daniel A. Giles United States 13 374 0.6× 201 0.4× 143 0.4× 71 0.3× 93 1.0× 19 804
Jason Behary Australia 8 316 0.5× 294 0.5× 116 0.3× 77 0.4× 101 1.1× 18 664
Qiongling Bao China 6 267 0.4× 318 0.6× 153 0.4× 62 0.3× 72 0.8× 10 476

Countries citing papers authored by Julia J. Witjes

Since Specialization
Citations

This map shows the geographic impact of Julia J. Witjes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia J. Witjes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia J. Witjes more than expected).

Fields of papers citing papers by Julia J. Witjes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia J. Witjes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia J. Witjes. The network helps show where Julia J. Witjes may publish in the future.

Co-authorship network of co-authors of Julia J. Witjes

This figure shows the co-authorship network connecting the top 25 collaborators of Julia J. Witjes. A scholar is included among the top collaborators of Julia J. Witjes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia J. Witjes. Julia J. Witjes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Attaye, Ilias, Julia J. Witjes, Annefleur M. Koopen, et al.. (2024). Oral Anaerobutyricum soehngenii augments glycemic control in type 2 diabetes. iScience. 27(8). 110455–110455. 6 indexed citations
2.
Mak, Anne Linde, Eveline Bruinstroop, Peter Henneman, et al.. (2023). Faecal Microbiota transplantation affects liver DNA methylation in Non-alcoholic fatty liver disease: a multi-omics approach. Gut Microbes. 15(1). 2223330–2223330. 45 indexed citations
3.
Troelstra, Marian, Anne‐Marieke van Dijk, Julia J. Witjes, et al.. (2022). Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease. Frontiers in Physiology. 13. 942495–942495. 8 indexed citations
4.
Koopen, Annefleur M., Eduardo L. Almeida, Ilias Attaye, et al.. (2021). Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome. Frontiers in Microbiology. 12. 662159–662159. 40 indexed citations
5.
Troelstra, Marian, Julia J. Witjes, Anne‐Marieke van Dijk, et al.. (2021). Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD‐NASH Cohort. Journal of Magnetic Resonance Imaging. 54(6). 1937–1949. 36 indexed citations
6.
Aron‐Wisnewsky, Judith, Chloé Vigliotti, Julia J. Witjes, et al.. (2020). Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nature Reviews Gastroenterology & Hepatology. 17(5). 279–297. 768 indexed citations breakdown →
7.
Lobatto, Mark E., Tina Binderup, Philip M. Robson, et al.. (2019). Multimodal Positron Emission Tomography Imaging to Quantify Uptake of 89Zr-Labeled Liposomes in the Atherosclerotic Vessel Wall. Bioconjugate Chemistry. 31(2). 360–368. 27 indexed citations
8.
Witjes, Julia J., Daniël H. van Raalte, & Max Nieuwdorp. (2015). About the gut microbiome as a pharmacological target in atherosclerosis. European Journal of Pharmacology. 763(Pt A). 75–78. 11 indexed citations
9.
Moens, Sophie J. Bernelot, Hans L. Mooij, H. Carlijne Hassing, et al.. (2014). Carriers of Loss-of-Function Mutations in EXT Display Impaired Pancreatic Beta-Cell Reserve Due to Smaller Pancreas Volume. PLoS ONE. 9(12). e115662–e115662. 13 indexed citations
10.
Brok, Melina G.H.E. den, et al.. (2013). NADP+-dependent IDH1R132 mutation and its relevance for glioma patient survival. Medical Hypotheses. 80(6). 728–731. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026